Showing results (1901-1910 of 2,401) with videos related to
Sort By:
Pageof 241
Resuscitation|December 15, 2010
A randomized controlled trial comparing traditional training in cardiopulmonary resuscitation (CPR) to self-directed CPR learning in first year medical students: The two-person CPR studyLynn P Roppolo, Rahm Heymann, Paul Pepe, et al.The Journal of International Medical Research|September 29, 2007
Hyperactive delirium and blood glucose control in critically ill patientsA Heymann, M Sander, D Krahne, et al.BMJ Supportive & Palliative Care|July 19, 2020
Oncology to specialised palliative home care systematic transition: the Domus randomised trialKirstine Benthien, Pernille Diasso, Annika von Heymann, et al.Hepatology (Baltimore, Md.)|October 28, 2011
Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in miceFelix Heymann, Linda Hammerich, Dunja Storch, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|July 13, 2005
[A rare cause of myocardial infarction: papillary fibroelastoma of the aortic valve]J P Gueffet, A Bammert, S Pattier, et al.Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Equity in the use of publicly subsidized psychotherapy among elderly Danish cancer patients--a register-based cohort studyAnnika B von Heymann-Horan, Pernille E Bidstrup, Luise C Kristiansen, et al.The Journal of Biological Chemistry|July 17, 2013
Three-dimensional structure of the toxin-delivery particle antifeeding prophage of Serratia entomophilaJ Bernard Heymann, Joseph D Bartho, Daria Rybakova, et al.Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|February 23, 2008
[The Nursing Delirium Screening Scale (NU-DESC)]Alawi Lütz, Finn M Radtke, Martin Franck, et al.The Annals of Thoracic Surgery|March 25, 2014
Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operationsHoward K Song, Christian von Heymann, Christian M Jespersen, et al.International Journal of Biological Macromolecules|March 21, 2025
A new promising anticancer agent: A glycosaminoglycan-mimetic derived from the marine bacterial infernan exopolysaccharideDominique Heymann, Javier Muñoz-Garcia, Antoine Babuty, et al.Pageof 241